Radko Komers, MD, PhD
Travere Therapeutics · Travere Therapeutics, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Radko Komers, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:09 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07219121 · Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental GlomerulosclerosisTravere Therapeutics, Inc. · active not recruiting · Proteinuria, Immunoglobulin A (IgA) Nephropathy, Focal Segmental Glomerulosclerosis · study director
- Ph2NCT05856760 · A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgANTravere Therapeutics, Inc. · completed · Immunoglobulin A Nephropathy · study director
- Ph2NCT05003986 · Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular DiseasesTravere Therapeutics, Inc. · recruiting · Focal Segmental Glomerulosclerosis, Minimal Change Disease, Immunoglobulin A Nephropathy · study director
- Ph3NCT03762850 · A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA NephropathyTravere Therapeutics, Inc. · completed · Immunoglobulin A Nephropathy · study director
- Ph3NCT03493685 · Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)Travere Therapeutics, Inc. · completed · Focal Segmental Glomerulosclerosis · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.